Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets

GlobeNewswire
2025.11.20 13:09
portai
I'm PortAI, I can summarize articles.

NEW YORK, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Psyence Biomedical Ltd. ( Nasdaq: PBM ) ( "Psyence BioMed" or the "Company" ) , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced it had established a sustainable ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer